Salarius subsidiary Decoy Therapeutics’ influenza fusion inhibitors, designed using its proprietary IMP3ACT™ platform, show excellent in silico ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global ...

It’s not something we are getting inundated with yet. It’s early in the season, so we do anticipate that it will go up." ...

Cold and flu season typically happen during the fall and winter. Though it comes around every year, there's still a lot of ...

Itvisma (onasemnogene abeparvovec-brve) demonstrated improved motor function and stabilization in patients regardless of SMA treatment history in Phase III studiesOne-time dose of Itvisma replaces ...

VBY329 is designed for the prevention of Respiratory Syncytial Virus (RSV) infections in newborns, infants, and children, and results from ...

The RSV shot isn't suggested for everyone like the flu vaccine is. Here's who is at risk and how to get a shot.

Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 Expects to expand seasonal vaccine franchise from three to up to six approved products ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the “Company”), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ...

Every Thanksgiving, while millions of Americans gather around tables laden with turkey and pie, emergency rooms brace for an ...

Doctronic reports heart attacks spike during Thanksgiving due to factors like rich food, stress, and disrupted routines.

Massachusetts could be headed for a sharp uptick in flu cases in the coming weeks, public health experts warn, as a newly ...